Search

A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD) (ENVISION)
A Randomized, Double-blind, Placebo-controlled Study of Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy (DMD)
Join Us
Leadership
Creating pathways to LGMD genetic diagnosis: Spotlight on LGMD Grant Award recipient
A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of SRP-9001 (Delandistrogene Moxeparvovec) in Participants With Duchenne Muscular Dystrophy (DMD) (EMBARK)
A Study of the Natural History of Participants With LGMD2E/​R4, LGMD2D/​R3, LGMD2C/​R5, and LGMD2A/​R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice
Homepage
Community Letter: ELEVIDYS Safety Update
A Study to Compare Safety and Efficacy of a High Dose of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)